INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for scleroderma lung disease: major trial underway
Disease control Recruiting nowThis study tests whether new investigational drugs can improve lung function in people with scleroderma-related lung scarring. About 400 adults with this condition will receive either the study drug or a placebo for 52 weeks. The main goal is to see if the drug helps preserve or …
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Phase: PHASE2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Scientists hunt for clues to stop rare, deadly scleroderma
Knowledge-focused Recruiting nowThis observational study aims to uncover why systemic sclerosis (SSc) develops and worsens. Researchers will analyze blood, skin, and DNA from 150 patients in Sweden to find markers linked to disease activity and progression. The goal is to improve diagnosis and identify new trea…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC